|
| |
Image Results
Loading...
Loading...
Syn X Pharmaceuticals Pages on BioPortfolio:
|
BioPortfolio - Nasal Mucosa
BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug ... Alpha-synuclein (alpha-SYN) is one of the major components of. ... P Q R S T
U V W X Y Z or by Most Publications, recently searched for, or most viewed. ...
http://www.bioportfolio.com/indepth/Nasal_Mucosa.html...
|
BioPortfolio - Lewy Body Disease
BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science ... Phosphorylation of alpha-synuclein (alpha-syn) at serine 129 (S129) is a. ... S
T U V W X Y Z or by Most Publications, recently searched for, or most viewed.
...
http://www.bioportfolio.com/indepth/Lewy_Body_Disease.html...
|
BioPortfolio - Mannitol Dehydrogenase
BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug ... The Hypocrea jecorina (syn. Trichoderma reesei) lxr1 gene encodes a ... R S
T U V W X Y Z or by Most Publications, recently searched for, or most viewed.
...
http://www.bioportfolio.com/indepth/Mannitol_Dehydrogenase.h...
|
BioPortfolio - Multiple System Atrophy
BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science ... Intracellular alpha-synuclein (alpha-syn) aggregates are the pathological. ... S
T U V W X Y Z or by Most Publications, recently searched for, or most viewed.
...
http://www.bioportfolio.com/indepth/Multiple_System_Atrophy....
|
BioPortfolio - Endopeptidase K
BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science ... alpha-Synuclein (alpha-syn) is a 140-residue protein of unknown function,. ... S
T U V W X Y Z or by Most Publications, recently searched for, or most viewed.
...
http://www.bioportfolio.com/indepth/Endopeptidase_K.html...
|
BioPortfolio - Catalytica Incorporated - Profile
subsidiaries: Catalytica Pharmaceuticals, Inc., Catalytica Combustion ... syn-1- (4-hydroxy-phenyl)-2-(4-hydroxy-4-phenyl-piperidin-1-yl)-1-propanol compounds
... 7181906- Devices and methods for reduction of NO.sub.x emissions from lean
...
http://www.bioportfolio.com/biocorporate/2475-Catalytica+Inc...
|
BioPortfolio - Toyocamycin
BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug ... A toyocamycin analogue with the sugar moiety in a syn conformation. ... R S
T U V W X Y Z or by Most Publications, recently searched for, or most viewed.
...
http://www.bioportfolio.com/indepth/Toyocamycin.html...
| Results from other life science and pharmaceutical sites:
BioSpace - SYN X Pharma Inc. News, Search Jobs, Events
19 Oct 2005 ... SYN X Pharma Inc. Wholly-Owned Subsidiary Of Nanogen 1 Marmac Drive Toronto Ontario M9W 1E7 Canada Phone: 416-798-3445 Fax: 416-798-3447 ...
http://www.biospace.com/company_profile.aspx?CompanyId=4400...
|
Total Synthesis of Cytotoxic Macrolide Amphidinolide B1 and the ...
The final selenide oxidation/syn elimination proved problematic under standard ... Dr. Roger Hanselmann (Rib-X Pharmaceuticals) for his helpful discussions.
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2435505/...
|
Unified Synthesis of C19–C26 Subunits of Amphidinolides B1, B2 ...
This modification provides access to both the Evans-syn product via the .... and Dr. Roger Hanselmann (Rib-X Pharmaceuticals) for his helpful discussions. ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=24...
|
syn-1,2-Amino Alcohols via Diastereoselective Allylic C–H Amination
syn-1,2-Amino alcohols are prevalent motifs in a diverse range of important small molecules such as natural products, pharmaceuticals, and asymmetric
catalysts. ..... Lei A, Liu G, Lu X. J Org Chem. 2002;67:974. [PubMed] ...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2720786/...
|
Structural properties of the [d(G3T4G3)]2 quadruplex: evidence for ...
Department of Pharmaceutical Chemistry, School of Pharmacy, University of ... These calculations suggest that the sequential syn-syn/anti-anti and syn-anti
quartet ... Kang C, Zhang X, Ratliff R, Moyzis R, Rich A. Crystal structure of
...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=33...
|
The biological activity of two symmetric amine derivatives of the ...
Department of Pharmaceutical Chemistry, Potchefstroom University for Christian ... atria by approximately 30% at concentrations of 1 x 10(-5) M or more. ...
http://www.ncbi.nlm.nih.gov/pubmed/8999428...
|
Current Alzheimer's Disease Treatments and Beyond: Advances ...
15 Jun 2004 ... CLOSE [X]. SPECIALTY SITES; Allergy & Clinical Immunology .... Novartis Pharmaceuticals, Pfizer Inc, Syn•X Pharma Inc., Wyeth. ...
http://www.medscape.com/viewarticle/481063_10...
|
Synthetic Studies toward Amphidinolide B1: Synthesis of the C9–C26 ...
).1 The relative stereochemistry of 1 was determined by X-ray crystal analysis,2 and ... 2314 gave the desired C21–C23 syn,syn adduct 25 in good yield. ... and
Dr. Roger Hanselmann (Rib-X Pharmaceuticals) for his helpful discussions. ...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2414262/...
|
Reissue Applications Filed - OG Date: 28 June 2005
... et al., Owner of Record: Syn X Pharma, Inc., Mississauga, Canada, Attorney or Agent: Gordon Kit, Ex. Gp.: 1641 6492684, Re. S.N. 11/004791, Dec. ...
http://www.uspto.gov/web/offices/com/sol/og/2005/week26/patr...
|
Rhenium(V) and Technetium(V) Oxo Complexes of an N(2)N'S Peptidic ...
Resolution Pharmaceuticals Inc., 6850 Goreway Drive, Mississauga, Ontario, ... of the syn isomer of the Re complex was determined by X-ray crystallography. ...
http://www.ncbi.nlm.nih.gov/pubmed/11670202...
|
|
